Okami Medical Appoints Bill Hoffman to Its Board of Directors
Okami Medical Appoints Bill Hoffman to Its Board of Directors
"I'm honored to join the Okami team and have been impressed by the performance of the LOBO vascular occluder in a wide variety of anatomies," commented Mr. Hoffman. "I look forward to working with the team to expand our commercial launch and make this important technology available to more physicians and patients."ALISO VIEJO, Calif., Dec. 3, 2024 /PRNewswire/ -- Okami Medical, a commercial-stage medical device company, today announced the appointment of Bill Hoffman to its Board of Directors.
加利福尼亞州阿利索維耶霍，2024年12月3日 / PRNewswire/ - 醫療靈開公司，一家商業階段的醫療器械公司，今天宣佈任命比爾·霍夫曼爲其董事會成員。
"We are thrilled to welcome Bill to our Board of Directors," said Rhonda Robb, President and CEO of Okami Medical. "Bill brings extensive experience in the medical device industry and is an exceptionally strong leader with a track record of driving growth while creating a culture of operational excellence."
醫療靈開公司總裁兼首席執行官朗達·羅布表示：「我們非常高興歡迎比爾加入我們的董事會。 比爾在醫療器械行業擁有豐富的經驗，是一位擁有卓越領導力的領導者，以推動增長並創造卓越運營文化而聞名。」
Mr. Hoffman is a Venture Partner at Vensana Capital. He serves as a member of the board of directors for several med tech companies, including Inari Medical, where he held the CEO role from 2015 until 2022, leading the company through its initial public offering and helping to establish it as the global leader in the treatment of venous thromboembolism. He previously served as CEO at Visualase, acquired by Medtronic in 2014, and VP Sales at FoxHollow Technologies, acquired by ev3 in 2007.
霍夫曼先生是Vensana Capital的風險合夥人。 他擔任幾家醫療科技公司董事會成員，包括醫療靈開公司，在那裏他擔任首席執行官一職，從2015年至2022年，帶領該公司進行首次公開招股，並幫助將其建立爲治療靜脈血栓栓塞症全球領導者。 他曾擔任Visualase的首席執行官，該公司於2014年被美敦力收購，以及FoxHollow Technologies的銷售副總裁，該公司於2007年被ev3收購。
"I'm honored to join the Okami team and have been impressed by the performance of the LOBO vascular occluder in a wide variety of anatomies," commented Mr. Hoffman. "I look forward to working with the team to expand our commercial launch and make this important technology available to more physicians and patients."
霍夫曼先生評論說：「很榮幸加入醫療靈開團隊，並對LOBO血管閉塞器在各種解剖結構中的表現印象深刻。」 「我期待與團隊合作，擴大我們的商業推出，並使這一重要技術能夠提供給更多醫生和患者。」
About Okami Medical
Okami Medical, Inc. is a privately held medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels. The company was created in 2017 by Inceptus Medical, a medical device incubator. The Inceptus team has a track record of creating innovative and successful companies including Inari Medical, Sequent Medical (acquired by Terumo in 2016) and MicroVention (acquired by Terumo in 2006). Okami is backed by members of the board of directors, Vensana Capital, U.S. Venture Partners (USVP), and medical device industry veterans. For more information, please visit .
關於Okami Medical
醫療靈開有限公司是一傢俬人持有的醫療器械公司，旨在通過開發用於閉塞外周血管的創新、多功能和直觀設備，滿足患者和醫生不斷變化的需求。 該公司成立於2017年，由醫療器械孵化器Inceptus Medical創建。 Inceptus團隊在創立創新成功公司方面有着成功記錄，包括醫療靈開、Sequent Medical（於2016年被特發公司收購）和MicroVention（於2006年被特發公司收購）。 醫療靈開得到了董事會成員、Vensana Capital、U.S. Venture Partners（USVP）和醫療器械行業資深人士的支持。 欲了解更多信息，請訪問。
Source:
Okami Medical, Inc.
949-446-9710
[email protected]
Source:
Okami Medical, Inc.
949-446-9710
[email protected]
SOURCE Okami Medical Inc.
消息來源Okami Medical Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
